INDICATIONS AND USAGE
Jakafi is a kinase inhibitor indicated for treatment of:
Please click here for Full Prescribing Information for Jakafi.
DOSAGE AND ADMINISTRATION
Doses should be individualized based on safety and efficacy. Starting doses per indication are noted below.
Myelofibrosis
Polycythemia Vera
Acute Graft-Versus-Host Disease
Chronic Graft-Versus-Host Disease
DOSAGE FORMS AND STRENGTHS
Tablets: 5 mg, 10 mg, 15 mg, 20 mg and 25 mg.
Please click here for Full Prescribing Information for Jakafi.
WARNINGS AND PRECAUTIONS
Please click here for Full Prescribing Information for Jakafi.
ADVERSE REACTIONS
To report SUSPECTED ADVERSE REACTIONS, contact Incyte Corporation at 1-855-463-3463 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
Please click here for Full Prescribing Information for Jakafi.
DRUG INTERACTIONS
Please click here for Full Prescribing Information for Jakafi.
USE IN SPECIFIC POPULATIONS
Please click here for Full Prescribing Information for Jakafi.
ICD Codes
Sponsored by Incyte Corporation
MAT-JAK-03734 03/22
INDICATIONS AND USAGE
Jakafi is a kinase inhibitor indicated for treatment of:
IMPORTANT SAFETY INFORMATION
Please click here for Full Prescribing Information for Jakafi.